Lundbeck A/S

Pharmaceuticals, Biotechnology and Life Sciences

Targets set1.5°CNet-Zero: Targets set

SBTI ID

40000685

Informations générales

Localisation

Denmark

Europe

Secteur d'activité

Pharmaceuticals, Biotechnology and Life Sciences

Type d'organisation

Corporate

Dernière mise à jour

02/05/2024

Objectifs à court terme (Near-Term)
Engagement de réduction des émissions à horizon 2029

Statut

Targets set

Classification

1.5°C

Année cible

2029

Progression vers l'objectif79%
2015 (année de référence)2029
Objectifs à long terme (Long-Term)
Engagement de réduction des émissions à horizon 2050

Statut

Targets set

Classification

1.5°C

Année cible

2050

Progression vers l'objectif31%
2015 (année de référence)2050
Description complète des objectifs

Overall Net-Zero Target: H. Lundbeck A/S commits to reach net-zero greenhouse gas emissions across the value chain by 2050. Near-Term Targets: H. Lundbeck A/S commits to reduce absolute scope 1 and 2 GHG emissions 42% by 2029 from a 2019 base year.* H. Lundbeck A/S commits to reduce absolute scope 3 GHG emissions from purchased goods and services, upstream transportation and distribution and business travel 25% within the same timeframe. *The target boundary includes land-related emissions and removals from bioenergy feedstocks. Long-Term Targets: H. Lundbeck A/S commits to reduce absolute scope 1, 2 and 3 GHG emissions 90% by 2050 from a 2019 base year.* *The target boundary includes land-related emissions and removals from bioenergy feedstocks.

Net-Zero

Statut

Targets set

Année cible

2050

Progression31%
Business Ambition 1.5°C

Statut

BA1.5 member

Date d'engagement

01/11/2019

Classification détaillée

The targets covering greenhouse gas emissions from company operations (scopes 1 and 2) are consistent with reductions required to keep warming to 1.5°C

Identifiants

ISIN

DK0061804770

LEI

5493006R4KC2OI5D3470

Source : Science Based Targets initiative | Données publiques